Geron
GERN
#6280
Rank
โ‚ฌ0.71 B
Marketcap
1,13ย โ‚ฌ
Share price
3.15%
Change (1 day)
-70.07%
Change (1 year)

Geron (GERN) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ0.10 Billion

According to Geron's latest financial reports the company's total debt is โ‚ฌ0.10 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Geron - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ0.11 B50.53%
2023-12-31โ‚ฌ77.7 M49.5%
2022-12-31โ‚ฌ51.97 M7.03%
2021-12-31โ‚ฌ48.56 M100.99%
2020-12-31โ‚ฌ24.16 M959.79%
2019-12-31โ‚ฌ2.27 M
2018-12-31N/A
2005-12-31โ‚ฌ0.04 M-98.06%
2004-12-31โ‚ฌ2.39 M-51.35%
2003-12-31โ‚ฌ4.91 M-80.25%
2002-12-31โ‚ฌ24.89 M26.21%
2001-12-31โ‚ฌ19.72 M-44.3%
2000-12-31โ‚ฌ35.41 M94.72%
1999-12-31โ‚ฌ18.18 M139.79%
1998-12-31โ‚ฌ7.58 M291.3%
1997-12-31โ‚ฌ1.93 M-17.86%
1996-12-31โ‚ฌ2.35 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
โ‚ฌ0.47 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ21.42 B 20,357.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚ฌ0.33 B 223.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚ฌ35.44 M-66.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
โ‚ฌ41.99 M-59.89%๐Ÿ‡บ๐Ÿ‡ธ USA